September 11, 2024 4:40 PM
Novo Nordisk experimental obesity pill has mild-to-moderate side effects in early trial
Novo Nordisk said on Wednesday that its highly anticipated experimental weight-loss pill amycretin was safe and tolerable for patients in an early-stage trial, with mild-to-moderate side effects. The maker of blockbuster drugs Wegovy and Ozempic sai...